{"SPADE_N_03137": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2002/0111305 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2002_0111305_A1", "Patent Type": "Patent Application", "Publication Date": "2008-1-1", "Family Info": "CA2353530A1,EP1147132A2,WO2000032629A2,WO2000032629A3", "Patent Title": "Antiviral peptides.", "Abstract": "The invention relates to peptides for use as antiviral agent, consisting of an amino acid chain which contains a domain of 10 to 25 amino acids, wherein the majority of the amino acids of the one half of the domain are positively charged amino acids and the majority of the amino acids of the other half of the domain are uncharged amino acids. The invention further relates to oligomers of these peptides consisting of at least two such peptides which are coupled to each other, optionally via a spacer, for use as antiviral agent, in addition to the use of the peptides and/or oligomers for the manufacture of a medicine for treating viral infections."}, {"Patent No": "US 10464977 B2", "Patent Link": "http://www.lens.org/lens/patent/US_10464977_B2", "Patent Type": "Granted Patent", "Publication Date": "2019-11-5", "Family Info": "US20170291930A1", "Patent Title": "Histatin-5 Based Synthetic Peptides And Uses Thereof", "Abstract": "Provided herein are synthetic peptides or synthetic fragments thereof based on a Histatin-5 peptide, for example with a sequence DSHAKRHHGYKRKFHEKHHSHRGY (SEQ ID NO: 1). The synthetic peptides or synthetic fragments have at least one substituted amino acid that is arginine and/or leucine to increase resistance to proteolytic degradation by a microbe, such as a fungus. The synthetic peptides or synthetic fragments thereof may be contained in a hydrogel. Also provided are methods for treating or preventing a pathophysiological condition via topical administration of the synthetic peptide or fragments. The pathophysiological condition may be a fungal or bacterial infection including associated inflammation or a chronic condition."}], "Sequence Information": {"SPADE ID": "SPADE_N_03137", "Peptide Name": "His3-(20-43)-peptide (Histatin 5; derivatives: Dh-5; Clinical)", "Source": "Homo sapiens (Human)", "Family": "Not found", "Gene": "Not found", "Sequence": "DSHAKRHHGYKRKFHEKHHSHRGY", "Sequence Length": 24, "UniProt Entry": ["http://www.uniprot.org/uniprot/P15516", "http://www.uniprot.org/uniprot/Q16243", "http://www.uniprot.org/uniprot/Q502Z1"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Antifungal"], "Target Organism": "Yeast:Candida albicans (100% inhibition at 54 nmol), Cryptococcus neoformans.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Metal-binding (Zinc)", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C133H195N51O33", "Mass": 3036.29, "PI": 10.28, "Net Charge": 12, "Hydrophobicity": -2.45, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:>10 hour", "Comments": "Histatin 5 is a proteolytic product of histatin 3. The active Domain of histitin 5 (Dh-5) corresponding to residues 11-24 showed HIV inhibitory effects. However,the results with the Dh-5 mutants are mixed (Groot et al. 2006 J. Virol. 80", "Literature": [{"Title": "Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.", "Pubmed ID": "3286634", "Reference": "J Biol Chem. 1988 Jun 5;263(16)7472-7477.", "Author": "Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=3286634"}], "Frequent Amino Acids": "HKR", "Absent Amino Acids": "CILMNOPQTUVW", "Basic Residues": 14, "Acidic Residues": 2, "Hydrophobic Residues": 4, "Polar Residues": 19, "Positive Residues": 14, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03135", "Similarity": 1.0, "Sequence": "DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN"}, {"SPADE_ID": "SPADE_N_03138", "Similarity": 1.0, "Sequence": "DSHAKRHHGYKRKFHEKHHSHRGYR"}, {"SPADE_ID": "SPADE_N_04202", "Similarity": 1.0, "Sequence": "MKFFVFALILALMLSMTGADSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN"}]}}}